U.S. health authorities on Tuesday recommended pausing the Johnson and Johnson COVID-19 shot over blood clot fears, with the company quicklyits European rollout, in a setback for global immunization campaigns. Out of nearly seven , six women aged between 18 and 48 developed a rare type of clot in the brain and low platelets, officials said.
President Joe Biden speaks to the media during a meeting with the Congressional Black Caucus in the Oval Office at the White House in Washington, D.C.” src=”https://sl.sbs.com.au/public/image/file/4fe1e8da-3c59-419d-87c8-b71c720ab0ec” alt=”with the Congressional Black Caucus in the Oval Office at the White House in Washington, D.C.” width=”700″ height=”467″ />
One later died while another was in critical condition.
Food and Drug Administration scientist Peter Marks said the disorder might be triggered by a rare immune response to the vaccine similar to that seen among a few hundred recipients of thein Europe.
Both vaccines are based on adenovirus vector technology.
“We have decided to delay the rollout of our vaccine in Europe proactively,” Johnson and Johnson said, in a fresh blow for the hard-hit continent which passed the threshold of one.
Thehas signed a deal for 200 million vaccine shots with an option for 200 million more.
U.S.investigating what could lead to tough regulatory choices, such as restricting the Johnson and Johnson shot to subsets of the population.
People who have received a Johnson and Johnson shot within the past threeto their doctors if they experienced severe headaches, abdominal pain, leg pain, or shortness of breath.
But thesaid it was confident there would be no “significant impact” on the vaccination plan in the world’s hardest-hit country, where almost half of all adults have now received at least one dose.
Jeff Zients, PresidentCOVID-19 response coordinator, said that a massive surplus in the supply of two other vaccines – Pfizer and Moderna – meant the country could easily take up the slack.
More than 800 millionglobally, according to an AFP tally.
India, experiencing a record, was boosted as it authorized Russia’s Sputnik V COVID-19 drug.
The total number of virus deaths is approaching three million, as theOrganisation warned that infections are rising exponentially despite efforts to stop them.
Muslims worldwide started Ramadan after religious leaders confirmed the fasting month would begin on Tuesday, with many countriesrestrictions.
Jakarta’s newly renovated Istiqlal Mosque –most prominent – welcomed worshippers for the first time after a year of closure because of the pandemic.
Mosques in thewill only host people at a maximum of 50 percent capacity. Worshippers are required to and bring their prayer mats.
Home to Islam’s holiest shrines, Saudi Arabia announced that the sacred fasting month would start on Tuesday. However, authorities said onlyto perform the year-round Umrah pilgrimage from the start of Ramadan.
“This year, for example, we won’t have the (large) iftars. And we can’t have a lot of people in the mosque. We have to queue and wait,” said 30-year-old Toparkhan Bergen.